| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Neurobiology, The Weizmann Institute of Science, Rehovot, Israel
Vaccination with peptides derived from interphotoreceptor retinoid-binding protein (a self-Ag that can cause experimental autoimmune uveoretinitis) resulted in protection of retinal ganglion cells from glutamate-induced death or death as a consequence of optic nerve injury. In the case of glutamate insult, no such protection was obtained by vaccination with myelin Ags (self-Ags associated with an autoimmune disease in the brain and spinal cord that evokes a protective immune response against consequences of injury to myelinated axons). We suggest that protective autoimmunity is the body’s defense mechanism against destructive self-compounds, and an autoimmune disease is the outcome of a failure to properly control such a response. Accordingly, the specific self-Ag (although not necessarily its particular epitopes) used by the body for protection against potentially harmful self-compounds (e.g., glutamate) can be inferred from the specificity of the autoimmune disease associated with the site at which the stress occurs (irrespectively of the type of stress) and is in need of help.
This article has been cited by other articles:
|
|
 |
|
  S. K. Garg, R. Banerjee, and J. Kipnis Neuroprotective Immunity: T Cell-Derived Glutamate Endows Astrocytes with a Neuroprotective Phenotype J. Immunol., March 15, 2008; 180(6): 3866 - 3873. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. V. Johnson, C. B. Camras, and J. Kipnis Bacterial DNA Confers Neuroprotection after Optic Nerve Injury by Suppressing CD4+CD25+ Regulatory T-Cell Activity Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3441 - 3449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bakalash, A. Rolls, O. Lider, and M. Schwartz Chondroitin Sulfate-Derived Disaccharide Protects Retinal Cells from Elevated Intraocular Pressure in Aged and Immunocompromised Rats Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1181 - 1190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Schori, E. Robenshtok, M. Schwartz, and A. Hourvitz Post-Intoxication Vaccination for Protection of Neurons against the Toxicity of Nerve Agents Toxicol. Sci., September 1, 2005; 87(1): 163 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Oppenheim, H. F. Dong, P. Plotz, R. R. Caspi, M. Dykstra, S. Pierce, R. Martin, C. Carlos, O. Finn, O. Koul, et al. Autoantigens act as tissue-specific chemoattractants J. Leukoc. Biol., June 1, 2005; 77(6): 854 - 861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Hauben, A. Gothilf, A. Cohen, O. Butovsky, U. Nevo, I. Smirnov, E. Yoles, S. Akselrod, and M. Schwartz Vaccination with Dendritic Cells Pulsed with Peptides of Myelin Basic Protein Promotes Functional Recovery from Spinal Cord Injury J. Neurosci., September 24, 2003; 23(25): 8808 - 8819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bakalash, A. Kessler, T. Mizrahi, R. Nussenblatt, and M. Schwartz Antigenic Specificity of Immunoprotective Therapeutic Vaccination for Glaucoma Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3374 - 3381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. N. Angelov, S. Waibel, O. Guntinas-Lichius, M. Lenzen, W. F. Neiss, T. L. Tomov, E. Yoles, J. Kipnis, H. Schori, A. Reuter, et al. Therapeutic vaccine for acute and chronic motor neuron diseases: Implications for amyotrophic lateral sclerosis PNAS, April 15, 2003; 100(8): 4790 - 4795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schwartz Neurodegeneration and Neuroprotection in Glaucoma: Development of a Therapeutic Neuroprotective Vaccine: The Friedenwald Lecture Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1407 - 1411. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
